SCHEMBL9604058

SCHEMBL9604058

C[Si](C)(C)c1ccc(/C=C/c2ccc(N(c3ccc(/C=C/c4ccc([Si](C)(C)C)cc4)cc3)c3ccc(/C=C/c4ccc([Si](C)(C)C)cc4)cc3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
RAB9A P51151 3/20 0.44
CASP1 P29466 2/20 0.44
HBB P68871 2/20 0.44
NPC1 O15118 2/20 0.44
ALOX15 P16050 1/20 0.44
RELA Q04206 1/20 0.42
APP P05067 7/20 0.41
ALDH1A1 P00352 2/20 0.37
HTT P42858 2/20 0.37
GAA P10253 1/20 0.37
BRCA1 P38398 1/20 0.37
CASP7 P55210 1/20 0.37
PTGS1 P23219 1/20 0.37
LMNA P02545 1/20 0.37
ALPG P10696 1/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12128520 0.94 MAPT (0.40) MAPTMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL12128483 0.94 MAPT (0.40) MAPTMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL14461262 0.89 ALOX5 (0.44) MAPTMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL15298706 0.89 MAPT (0.37) MAPTMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL19735992 0.88 MAPT (0.36) MAPTMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL30307012 0.88 CYP1A2 (0.51) MAPTSMN1; SMN2RAB9ANPC1RELA
SCHEMBL20910232 0.88 MAPT (0.36) MAPTMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL26410129 0.88 CYP1A1 (0.46) MAPTMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL13636797 0.88 CYP1A2 (0.42) MAPTMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL13636801 0.88 CYP1A2 (0.42) MAPTMEN1KMT2ASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240244957-A1 FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL Merck Patent KGaA (DE) 2024-07-18 US disclosed
EP-3387077-B1 FORMULATIONS CONTAINING KETONES COMPRISING NON-AROMATIC CYCLES MERCK PATENT GMBH (DE) 2023-10-18 EP disclosed
US-11770971-B2 Esters containing aromatic groups as solvents for organic electronic formulations MERCK PATENT GMBH (DE) 2023-09-26 US disclosed
US-11770971-B2 Esters containing aromatic groups as solvents for organic electronic formulations MERCK PATENT GMBH (DE) 2023-09-26 US disclosed
US-11672174-B2 Pyrene-triazine derivative and applications thereof in organic electronic component GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2023-06-06 US disclosed
US-11672174-B2 Pyrene-triazine derivative and applications thereof in organic electronic component GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2023-06-06 US disclosed
US-11538992-B2 Formulation of an organic functional material MERCK PATENT GMBH (DE) 2022-12-27 US disclosed
EP-3390549-B1 FORMULATIONS CONTAINING A SOLID SOLVENT MERCK PATENT GMBH (DE) 2022-06-29 EP disclosed
US-20220102649-A1 ESTERS CONTAINING AROMATIC GROUPS AS SOLVENTS FOR ORGANIC ELECTRONIC FORMULATIONS MERCK PATENT GMBH (DE) 2022-03-31 US disclosed
US-20220013724-A1 METHOD FOR FORMING AN ORGANIC ELEMENT OF AN ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2022-01-13 US disclosed
US-20120326141-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2012-12-27 US disclosed
US-20120298981-A1 STYRENE-BASED COPOLYMERS, IN PARTICULAR FOR USE IN OPTOELECTRONIC COMPONENTS MERCK PATENT GMBH (DE) 2012-11-29 US disclosed
US-20120299045-A1 ORGANIC ELECTROLUMINESCENT DEVICE WITH INTEGRATED LAYER FOR COLOUR CONVERSION MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) 2012-11-29 US disclosed
US-8304095-B2 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-11-06 US disclosed
US-20120245658-A1 Therapeutic and Cosmetic Electroluminescent Compositions MERCK PATENT GMBH (DE) 2012-09-27 US disclosed
US-20120238105-A1 FORMULATIONS FOR THE PRODUCTION OF ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-09-20 US disclosed
US-20120132898-A1 ELECTRONIC DEVICES COMPRISING MULTI CYCLIC HYDROCARBONS MERCK PATENT GMBH (DE) 2012-05-31 US disclosed
US-20110108821-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2011-05-12 US disclosed
US-20080297037-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-12-04 US disclosed
US-20080272693-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238105-A1 FORMULATIONS FOR THE PRODUCTION OF ELECTRONIC DEVICES NR3C2, KCNE1, KCNJ2 MAPT 4257/4885MEN1 1758/4885KMT2A 1036/4885
US-20120298981-A1 STYRENE-BASED COPOLYMERS, IN PARTICULAR FOR USE IN OPTOELECTRONIC COMPONENTS EYA3, PDE6C, ETV6 MAPT 2744/4885MEN1 3584/4885KMT2A 4512/4885
US-11672174-B2 Pyrene-triazine derivative and applications thereof in organic electronic component TPR, TRPC5, TRPC4 MAPT 509/4885MEN1 4828/4885KMT2A 4435/4885
US-20080272693-A1 Organic Electroluminescent Devices EML4, MT-ND4L, EPCAM MAPT 398/4885MEN1 3327/4885KMT2A 1866/4885
US-20120245658-A1 Therapeutic and Cosmetic Electroluminescent Compositions LPO, TYR, GPX1 MAPT 1286/4885MEN1 1657/4885KMT2A 3201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.